KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to -$24.0 million.

  • Bausch Health Companies' Deferred Taxes fell 70000.0% to -$24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $95.0 million, marking a year-over-year increase of 57500.0%. This contributed to the annual value of $66.0 million for FY2024, which is 2941.18% up from last year.
  • Per Bausch Health Companies' latest filing, its Deferred Taxes stood at -$24.0 million for Q3 2025, which was down 70000.0% from -$42.0 million recorded in Q2 2025.
  • Bausch Health Companies' 5-year Deferred Taxes high stood at $170.0 million for Q4 2024, and its period low was -$106.0 million during Q2 2021.
  • Over the past 5 years, Bausch Health Companies' median Deferred Taxes value was -$20.5 million (recorded in 2021), while the average stood at -$19.9 million.
  • Its Deferred Taxes has fluctuated over the past 5 years, first surged by 34210.53% in 2023, then crashed by 70000.0% in 2025.
  • Bausch Health Companies' Deferred Taxes (Quarter) stood at -$88.0 million in 2021, then surged by 121.59% to $19.0 million in 2022, then surged by 342.11% to $84.0 million in 2023, then soared by 102.38% to $170.0 million in 2024, then tumbled by 114.12% to -$24.0 million in 2025.
  • Its last three reported values are -$24.0 million in Q3 2025, -$42.0 million for Q2 2025, and -$9.0 million during Q1 2025.